Introduction
============

Lung cancer is one of the most malignant tumors that are frequently seen in clinical practice. It is associated with an extremely high morbidity rate and mortality rate. Lung cancer ranks first among general malignant tumors, which can severely threaten the physical health of human beings ([@b1-ol-0-0-7789]). Lung cancer can be categorized into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC composes almost 80% of the lung cancer cases ([@b2-ol-0-0-7789]). Various treatment methods have been developed for NSCLC, including surgeries, chemotherapy and radiotherapy, in which surgeries have been considered as the preferred choice for treatment of NSCLC in the early stage. After surgeries, 50--80% patients experience a 5-year survival period ([@b3-ol-0-0-7789],[@b4-ol-0-0-7789]). With an advancement of medical techniques and instruments, thoracoscope-assisted segmental resection of lungs have become the major method in the surgical treatment of lung cancer, and shows excellent efficacy, particularly for the elderly patients or patients with poor cardiac or pulmonary functions ([@b5-ol-0-0-7789]). In this study, we performed thoracoscope-assisted segmental resection of lung for patients with NSCLC at the early stage, and observed the short- and long-term efficacy to provide a reference for the surgical treatment of NSCLC at the early stage.

Materials and methods
=====================

### Sample selection

We selected a total of 86 patients with NSCLC that were admitted to The First People\'s Hospital of Xuzhou for treatment between December 2010 and December 2011. Using a random number table, we divided them in to the control group (n=43) and the observation group (n=43). The inclusion criteria included: a) Patients that were diagnosed with NSCLC at the early stage according to results of computed tomography (CT) and pathological examinations, b) patients with the peripheral nodule diameters ≤2 cm, c) patients without any history of surgery, chemotherapy or radiotherapy, and d) patients who signed the informed consent form. Exclusion criteria included, a) patients with abnormal coagulation function, b) patients with NSCLC above stage III A, c) patients with a history of thoracic surgeries, or with lymph node metastasis in hilum of lung and mediastinum or distant metastasis. Comparison of the baseline characteristics of patients between the two groups showed no statistically significant differences (P\>0.05; [Table I](#tI-ol-0-0-7789){ref-type="table"}). The study was approved by the Ethics Committee of The First People\'s Hospital of Xuzhou.

### Pre-surgery preparation

Routine examinations were carried out before surgery for patients to exclude surgical contradiction and ascertain the optimal surgical time. At 2 weeks before surgery, patients were required to quit smoking. Food and water was withdrawn at 8 h before surgery.

### Treatment

All patients received general intravenous anesthesia with trachea cannula in the lateral position. During surgery, the arterial blood gases, arterial blood pressure, pulse and electrocardiography were monitored. Patients in the control group received conventional thoracic surgery in following procedures. After the sterile drape was covered on the surgical site, the lateral approach was prepared for opening the chest layer by layer. The mediastinal lymph nodes were resected followed by a routine resection of lobes of the lung. Warm saline was used to rinse the thoracic cavity after the surgery, and the air leakage was examined in the lung. The residual bronchial ends with the drainage tube being detained into the chest. The incision was closed through suturing.

In the observation group, patients received the thoracoscope-assisted segmental resection of lung through 3 ports: The observation port was prepared in the 7th and 8th intercostal space along the midline of the lateral axillary, which is approximately 1 cm. The main operation port was located in the intercostal space between the 4th and 5th rib along the anterior axillary line, which is approximately 3 cm. The auxiliary operation port in the 8th intercostal space along the infrascapular line, which is approximately 1 cm. Under the view of video, the resection of different pulmonary segments was performed with the lymph nodes being resected. After surgery, surgeons examined the dilation of residual lung, air leakage in lung or the residual bronchial end. The drainage tube was inserted into the thoracic cavity followed by suture of incision.

### Indicators of detection

Before surgery and at 1 week after surgery, we collected 5 ml of fasting peripheral venous blood from the patients in both groups, and the samples were used for enzyme-linked immunosorbent assay ELISA to determine levels of interleukin 6 (IL-6), interleukin 8 (IL-8) and tumor necrosis factor-α (TNF-α). The appropriate kits were purchased from Beijing Biolab Science and Technology Co. Ltd. (Beijing, China) and the procedures were conducted in strict accordance with the manufacturer\'s instructions. The levels of IL-6, IL-8 and TNF-α were calculated using optical density (OD) values at a wavelength of 450 nm, detected by a microplate reader (Jiangsu Potebio Biotechnology Co., Ltd., Jiangsu, China). With kits purchased from Zhejiang Ikon Biotechnology Co., Ltd. (Zhejiang, China), immunoturbidimetry was conducted to detect levels of IgG, IgA and IgM in serum of patients in strict accordance with the instructions of the kit. The turbidity of the reaction solution was used to detect the content of IgG, IgA and IgM in samples with the standard substance as a reference. In the samples, CD3^+^, CD4^+^ and CD8^+^ antibodies were added, respectively, and then incubated for 30 min in the dark at 4°C. Flow cytometer (BD, USA) was used to detect levels of T lymphocyte subgroups (CD3^+^, CD4^+^ and CD8^+^).

### Evaluation indicators

We compared the surgical efficacy of patients between the groups, including the intraoperative bleeding volume and the number of resected lymph nodes. After surgery, pain was evaluated using a visual analogue scale (VAS) within the range of scores between 0 and 10 points (0 point for no pain, and 10 points for intolerable acute pain). The comparison of postoperative complications was also conducted through recording the incidence rates of hyperthermia, persistent air leakage, cardiac arrhythmia, and pulmonary atelectasis.

Before surgery and at 1 week after surgery, 5 ml of fasting venous blood was drawn from patients in the morning who had been fasting for 8 h. The samples were used for detecting the levels of IL-6, IL-8 and TNF-α in serum of patients through ELISA. Immunoturbidimetry was conducted to measure the levels of IgG, IgA and IgM, and the levels of T lymphocyte subgroups (CD3^+^, CD4^+^, CD8^+^ and CD4^+^/CD8^+^) were detected using flow cytometry. Before surgery and at 3 months post-surgery, we examined the cardiac and pulmonary functions of patients, including the following indicators: heart rate (HR), forced expiratory volume in one second (FEV1), maximal voluntary ventilation (MVV) and carbon monoxide-diffusing capacity (DLCO).

During the 5-year follow-up, we collected statistics of recurrence rate, disease-free survival (DFS) and 5-year survival rate, in which the DFS was defined from the 1st day after surgery to the day of first onset of recurrence or metastasis, and 5-year survival was defined as the patients had no recurrence or metastasis within the 5-year follow-up.

### Statistical analysis

SPSS 19.0 (SPSS Inc., Chicago, IL, USA) was used to perform data processing. Measurement data are presented as mean ± standard deviation, and t-test was performed for intergroup comparison. The count data were presented as a rate, and a Chi-square test was performed for comparison of countable data. The Kaplan-Meier curve was applied in the survival analysis. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparison of surgical efficacy of patients between the groups

In the observation group, the intraoperative bleeding volume of patients was significantly less than that in the control group. In addition, the surgical duration was respectively short and the postoperative pain was alleviated compared to the control group (P\<0.05). There were no statistically significant differences in comparison of the number of resected lymph nodes of patients between the groups (P\>0.05; [Table II](#tII-ol-0-0-7789){ref-type="table"}).

### Comparison of incidence rates of postoperative complications of patients between the two groups

In the observation group, the rate of complications, including hyperthermia, persistent air leakage (\>1 week), cardiac arrhythmia and pulmonary atelectasis, was 6.98%, while the rate of complications in the control group was 30.23%, suggesting that the rate in the observation group was significantly lower than that in the control group (P\<0.05; [Table III](#tIII-ol-0-0-7789){ref-type="table"}).

### Comparison of the levels of inflammatory cytokines of patients between the groups

At 1 week after surgery, the levels of TNF-α, IL-6 and IL-8 of patients in both groups were remarkably elevated, and the elevation in the control group was more significant than that in the observation group (P\<0.05; [Table IV](#tIV-ol-0-0-7789){ref-type="table"}).

### Comparison of the cardiac and pulmonary functions of patients at 3 months after surgery between the two groups

There was significant improvement seen in the cardiac and pulmonary function of these two groups, and the improvement in the observation group was superior to that of the control group (P\<0.05; [Table V](#tV-ol-0-0-7789){ref-type="table"}).

### Comparison of immunoglobulin levels of patients between the groups

At 1 week after surgery, the levels of IgG, IgA and IgM of patients of both groups were decreased, and the decrease in the control group was more significant than that in the observation group (P\<0.05; [Table VI](#tVI-ol-0-0-7789){ref-type="table"}).

### Comparison of levels of T lymphocyte subgroups in serum of patients between the two groups

In these two groups, the levels of CD3^+^, CD4^+^, CD8^+^ and CD4^+^/CD8^+^ were decreased, and the decrease in the control group was more significant than that in the observation group (P\<0.05; [Table VII](#tVII-ol-0-0-7789){ref-type="table"}).

### Comparison of the recurrence rate and survival of patients between the groups

In the observation group, the average survival duration of patients was significantly longer than that in the control group, the recurrence rate was significantly lower than that in the control group, and the 5-year survival rate after surgery was significantly higher than that in the control group (P\<0.05; [Table VIII](#tVIII-ol-0-0-7789){ref-type="table"} and [Fig. 1](#f1-ol-0-0-7789){ref-type="fig"}).

Discussion
==========

Lung cancer is the most clinically common primary malignant tumor of the lung; it is also known as bronchial lung cancer for its origins in the bronchial epithelium ([@b6-ol-0-0-7789]). Various factors can contribute to the onset of NSCLC, including smoking, occupational carcinogens, air pollution, ionized radiation, diet, nutrition and variations in genes and heritability ([@b7-ol-0-0-7789]). Currently, the pathogenesis of NSCLC remains unclear yet, it is believed to be caused by the malignant proliferation of mutated cells due to an adverse microenvironment in local parts ([@b8-ol-0-0-7789]). Affected by various factors and the invasion of exogenous carcinogens into the lung, the body initiates a routine immune mechanism to minimize damage to the pulmonary tissues and functions by limitation, neutralization, elimination and eradication. Simultaneously, seal-repair is also conducted in pulmonary tissues and functions. Once the factors that contribute to the damage cannot be eradicated thoroughly in the body, a small number of factors will be stagnated in local parts of the lung. Although this may not cause acute stress response and extensive damage to the lung, it can result in persistent inflammation of local parts, which, together with the continuous repair of the micro-damage through the repair mechanism, can lead to significant difference between affected regions and the surrounding tissues in normal metabolism. With extension of time, these parts will evolve into adverse microenvironment in the local parts, whereas cells in normal pulmonary tissues would not be able to adapt to the adverse environment, and go into a differentiation phase, which can weaken the repair capability, and facilitate loss of control, thereby forming malignant proliferation and generation of NSCLC tumors ([@b9-ol-0-0-7789],[@b10-ol-0-0-7789]).

With a continuous increase in the healthcare awareness of people and the development of modern medical imaging techniques, NSCLC is apt to be discovered at an early stage, which has brought opportunities for patients to receive the early-stage treatment, and made surgical treatment into a preferred treatment method ([@b11-ol-0-0-7789]). Segmental bronchi, together with a bronchial tree and surrounding pulmonary tissues, constitutes the bronchopulmonary segments, also known as pulmonary segments. There are 8 segments in the left lung, and ten in right lung with the tip in the radix pulmonis and the root on the surface of lung ([@b12-ol-0-0-7789]). The independent artery, bronchi and the vein share with adjacent pulmonary segment, which consists of the independent bronchial tree and the relatively independent blood-supply circulation system into each pulmonary segment, which endows segmental resection with clinical availability ([@b13-ol-0-0-7789]). With a continuous development in the micro-invasive technique, thoracoscope-assisted segmental resection has become increasingly popular among elderly patients that are more susceptible to various diseases and have difficulties in conventional thoracic surgeries ([@b14-ol-0-0-7789]). In this study, results show that in comparison of surgical efficacy between the two groups, the intraoperative bleeding amount, surgical duration and the postoperative pain in the observation group is significantly reduced, shortened and alleviated, respectively, and the incidence rate of postoperative complications in the observation group is significantly lower than that in the control group (P\<0.05). In addition, there was no significant difference in the comparison of the number of resected lymph nodes between the groups (P\>0.05). The results suggest that thoracoscope-assisted surgery can maximally shorten the surgical duration, reduce intraoperative bleeding amount for its small surgical incision and alleviate postoperative pain. Particularly for elderly patients, this surgical method results in fewer injuries and a lower incidence rate of postoperative complications.

The results of this study show that at 1 month post-surgery, the cardiac and pulmonary function in both groups were significantly improved, and the improvement in the observation group was more significant than in the control group (P\<0.05). This may be due to thoracoscope-assisted segmental resection, which on the premise of guaranteeing the surgical efficacy, maximally retains the function of residual lung of patients, and is superior to conventional thoracic surgery in terms of FEV1. Moreover, small surgical parts can be magnified on the video screen, alleviate the damage to the lung and effectively protect the pulmonary function of patients, which is more conducive to the postoperative recovery of patients ([@b15-ol-0-0-7789]).

Most NSCLC patients suffer from poor cellular immune function, and, moreover, the stress responses caused by anesthesia and surgeries will further inhibit immune functions, resulting in disorders of immune function with inflammatory reactions, and postoperative infection of patients ([@b16-ol-0-0-7789]). The results of this study reveal that the levels of TNF-α, IL-6 and IL-8 at 1 week post-surgery in both groups were significantly increased, and the increase in the control group was more significant than those in the observation group. At 1 week post-surgery, the levels of IgG, IgA and IgM of the patients in two groups were reduced, and the decreases in the control group was more significant than those in the observation group. In addition, the levels of CD3^+^, CD4^+^, CD8^+^ and CD4^+^/CD8^+^ were reduced in the two groups, and the reductions in the control group were more significant than those in the observation group (P\<0.05). This is due to the fact that thoracoscope-assisted segmental resection results in fewer traumas, slighter stress responses and less activation to the reactions in the immune system. Consequently, the secretion of inflammatory factors, including TNF-α, IL-6 and IL-8, is reduced. In addition, with features such as precision and micro-invasion, thoracoscope-assisted segmental resection brings less injury to normal immune functions, and scarcely affects normal postoperative levels of IgG, IgA and IgM of patients ([@b17-ol-0-0-7789]). In the body, CD3^+^ assists to identify the receptor of antibodies in T cells ([@b18-ol-0-0-7789]), CD4^+^ T cells, with the regulatory function in the immune system, participates in the activation of CD8^+^ T cells as an assistant role ([@b19-ol-0-0-7789]), and the activated CD8^+^ T cells eliminates cells infected by virus and tumor cells ([@b20-ol-0-0-7789]). Thoracoscope-assisted segmental resection poses lower injury on the immune functions of patients, thereby resulting in a less significant decrease in the capability of an immune response to tumors.

The results of this study show that when comparing the recurrence rate and survival of patients between the groups, the average survival duration of patients in the observation group was significantly longer than that in the control group, and the recurrence rate was significantly lower than that in the control group. The 5-year survival rate after surgery was higher than that in the control group (P\<0.05). This is due to the slight trauma caused by thoracoscope-assisted segmental resection, which causes relatively mild inflammatory responses, little influence on immune functions, and significant short- and long-term efficacy, which remarkably augments the postoperative survival rate and prolongs survival duration of patients. In addition, the long-term efficacy of thoracoscope-assisted segmental resection is more evident than that of conventional thoracic surgery.

In conclusion, for the treatment of NSCLC, thoracoscope-assisted segmental resection has a more evident short- and long term efficacy and higher security. Thus, it is worthy of being promoted in clinical practice.
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###### 

Comparison of general materials of patients between the two groups.

  Characteristics          Control group (n=47)   Observation group (n=47)   t-value/χ^2^   P-value
  ------------------------ ---------------------- -------------------------- -------------- ---------
  Sex (male/female)        29/18                  27/20                      0.044          0.836
  Age (years)              40--75                 40--78                                    
  Average age (years)      57.69±7.69             58.24±7.53                 0.350          0.727
  Smoking (n, %)                                                                            
    Cigarette amount ≥5    19 (40.43)             16 (34.04)                 0.325          0.850
    Cigarette amount \<5     9 (19.15)            10 (21.28)                                
    No smoking             19 (40.43)             21 (44.68)                                

###### 

Comparison of surgical condition of patients between the two groups.

  Group               Case   Surgical duration (min)   Intraoperative bleeding amount (ml)   Number of resected lymph nodes (n)   Score of postoperative pain (point)
  ------------------- ------ ------------------------- ------------------------------------- ------------------------------------ -------------------------------------
  Observation group   47     124.73±8.05               216.43±11.63                          7.23±1.56                            2.58±1.57
  Control group       47     165.24±8.37               325.86±18.78                          7.56±2.47                            5.56±1.48
  t-value                    23.951                    33.936                                0.774                                9.469
  P-value                    \<0.001                   \<0.001                               0.441                                \<0.001

###### 

Comparison of the incidence rate of postoperative complications of patients between the two groups (n, %).

  Group               Case   Hyperthermia   Persistent air leakage   Cardiac arrhythmia   Pulmonary atelectasis
  ------------------- ------ -------------- ------------------------ -------------------- -----------------------
  Observation group   47     0 (0.00)       0 (0.00)                 1 (2.13)             1 (2.13)
  Control group       47     4 (8.51)       3 (6.38)                 2 (4.26)             4 (8.51)
  χ^2^                                      7.932                                         
  P-value                                   0.005                                         

###### 

Comparison of the levels of inflammatory cytokines of patients between the two groups (ng/l).

  Group               Time             Case   TNF-α                                                                                                  IL-6                                                                                                  IL-8
  ------------------- ---------------- ------ ------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  Observation group   Before surgery   47     62.64±6.28                                                                                             56.36±4.27                                                                                            73.52±3.16
                      After surgery    47     106.56±6.63^[a](#tfn1-ol-0-0-7789){ref-type="table-fn"},[b](#tfn2-ol-0-0-7789){ref-type="table-fn"}^   95.47±6.36^[a](#tfn1-ol-0-0-7789){ref-type="table-fn"},[b](#tfn2-ol-0-0-7789){ref-type="table-fn"}^   117.56±8.74^[a](#tfn1-ol-0-0-7789){ref-type="table-fn"},[b](#tfn2-ol-0-0-7789){ref-type="table-fn"}^
  Control group       Before surgery   47     62.83±3.57                                                                                             56.74±4.52                                                                                            73.85±3.47
                      After surgery    47     123.39±8.24^[a](#tfn1-ol-0-0-7789){ref-type="table-fn"}^                                               116.56±9.53^[a](#tfn1-ol-0-0-7789){ref-type="table-fn"}^                                              135.62±9.83^[a](#tfn1-ol-0-0-7789){ref-type="table-fn"}^

P\<0.05 compared with the levels before surgery

P\<0.05 compared with the levels in the control group.

###### 

Comparison of the cardiac and pulmonary functions of patients between the two groups.

  Group               Time             Case   HR (bpm)                                                                                              FEV1 (%)                                                                                             MVV (%)                                                                                               DLCO (%)
  ------------------- ---------------- ------ ----------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Observation group   Before surgery   47     69.87±6.54                                                                                            1.96±0.36                                                                                            68.63±3.73                                                                                            77.57±3.26
                      After surgery    47     82.76±6.75^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"},[b](#tfn4-ol-0-0-7789){ref-type="table-fn"}^   1.67±0.32^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"},[b](#tfn4-ol-0-0-7789){ref-type="table-fn"}^   74.59±3.84^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"},[b](#tfn4-ol-0-0-7789){ref-type="table-fn"}^   67.74±3.04^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"},[b](#tfn4-ol-0-0-7789){ref-type="table-fn"}^
  Control group       Before surgery   47     70.32±6.18                                                                                            1.93±0.27                                                                                            69.54±3.56                                                                                            78.13±3.47
                      After surgery    47     96.53±7.43^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"}^                                               1.44±0.25^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"}^                                               61.57±3.14^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"}^                                               71.25±3.16^[a](#tfn3-ol-0-0-7789){ref-type="table-fn"}^

P\<0.05 compared with the levels before surgery

P\<0.05 compared with the levels in the control group.

###### 

Comparison of immunoglobulin levels of patients between the two groups.

  Group               Time             Case   IgG                                                                                                   IgA                                                                                                  IgM
  ------------------- ---------------- ------ ----------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  Observation group   Before surgery   47     14.64±3.28                                                                                            2.16±0.27                                                                                            1.27±0.16
                      After surgery    47     12.58±2.73^[a](#tfn5-ol-0-0-7789){ref-type="table-fn"},[b](#tfn6-ol-0-0-7789){ref-type="table-fn"}^   1.87±0.18^[a](#tfn5-ol-0-0-7789){ref-type="table-fn"},[b](#tfn6-ol-0-0-7789){ref-type="table-fn"}^   1.06±0.12^[a](#tfn5-ol-0-0-7789){ref-type="table-fn"},[b](#tfn6-ol-0-0-7789){ref-type="table-fn"}^
  Control group       Before surgery   47     14.58±3.14                                                                                            2.13±0.23                                                                                            1.25±0.14
                      After surgery    47     9.57±2.15^[a](#tfn5-ol-0-0-7789){ref-type="table-fn"}^                                                1.46±0.15^[a](#tfn5-ol-0-0-7789){ref-type="table-fn"}^                                               0.97±0.08^[a](#tfn5-ol-0-0-7789){ref-type="table-fn"}^

P\<0.05 compared with the levels before surgery

P\<0.05 compared with the levels in the control group.

###### 

Comparison of levels of T lymphocyte subgroups in serum of patients between the two groups.

  Group               Time             Case   CD3^+^                                                                                                CD4^+^                                                                                                CD8^+^                                                                                                CD4^+^/CD8^+^
  ------------------- ---------------- ------ ----------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  Observation group   Before surgery   47     62.25±3.78                                                                                            36.85±2.27                                                                                            28.53±2.16                                                                                            1.82±0.26
                      After surgery    47     53.56±3.13^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"},[b](#tfn8-ol-0-0-7789){ref-type="table-fn"}^   31.43±2.16^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"},[b](#tfn8-ol-0-0-7789){ref-type="table-fn"}^   23.16±2.04^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"},[b](#tfn8-ol-0-0-7789){ref-type="table-fn"}^   1.52±0.14^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"},[b](#tfn8-ol-0-0-7789){ref-type="table-fn"}^
  Control group       Before surgery   47     63.84±3.46                                                                                            37.13±2.24                                                                                            28.67±2.16                                                                                            1.85±0.27
                      After surgery    47     46.23±3.16^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"}^                                               25.38±2.06^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"}^                                               19.54±1.89^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"}^                                               1.37±0.13^[a](#tfn7-ol-0-0-7789){ref-type="table-fn"}^

P\<0.05 compared with the levels before surgery

P\<0.05 compared with the levels in the control group.

###### 

Comparison of the condition of patients in a five-year follow-up between the two groups.

  Group               Case   Five-year survival (n, %)   Recurrence rate (n, %)   Average survival duration (month)
  ------------------- ------ --------------------------- ------------------------ -----------------------------------
  Observation group   47     33 (70.21)                  2 (4.26)                 49.76±7.75
  Control group       47     22 (46.81)                  13 (27.65)               40.83±7.68
  χ^2^/t-value               4.382                       7.932                    5.611
  P-value                    0.036                       0.005                    \<0.001
